CD8A and neoplasm: Specifically, ART1-mediated acidification of P2X7R on CD8+ T cells appears to contribute to tumor immune resistance 43, 44, while P2X7R activation in antigen-presenting dendritic cells enhances neoplastic immunogenicity and amplifies the antitumor effects of anti-PD-1 antibodies 45.